Literature DB >> 24459604

Updates on Hepato-Renal Syndrome.

Kyota Fukazawa1, H Thomas Lee1.   

Abstract

Hepato-renal syndrome (HRS) is one of the most detrimental conditions in patients with end stage liver failure. Historically, HRS was considered a terminal disease associated with cirrhosis and was termed "liver-death syndrome". Furthermore, despite the improved understanding of pathophysiology and the reversibility of renal dysfunction in HRS, mortality remains extremely high especially for type 1 HRS. This review summarizes the recent advances in the pathophysiology, diagnosis and management of HRS and also provides an evolving area of research in the pathophysiologic mechanisms of HRS, which may open the door for new therapeutic approaches.

Entities:  

Keywords:  Acute kidney injury; Cirrhosis; Endothelial cell; Inflammation

Year:  2013        PMID: 24459604      PMCID: PMC3897161          DOI: 10.4172/2155-6148.1000352

Source DB:  PubMed          Journal:  J Anesth Clin Res        ISSN: 2155-6148


  79 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

3.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Authors:  Richard Moreau; Francois Durand; Thierry Poynard; Christian Duhamel; Jean-Paul Cervoni; Philippe Ichaï; Armand Abergel; Chantal Halimi; Mathieu Pauwels; Jean-Pierre Bronowicki; Emile Giostra; Cathy Fleurot; Danielle Gurnot; Olivier Nouel; Philippe Renard; Michel Rivoal; Pierre Blanc; Dimitri Coumaros; Sylvie Ducloux; Stephane Levy; Alexandre Pariente; Jean-Marc Perarnau; Jean Roche; Myriam Scribe-Outtas; Dominique Valla; Brigitte Bernard; Didier Samuel; Joël Butel; Antoine Hadengue; Andrzej Platek; Didier Lebrec; Jean-Francois Cadranel
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

4.  Renal failure in patients with cirrhosis of the liver. 3. Evaluation of intrarenal blood flow by para-aminohippurate extraction and response to angiotensin.

Authors:  E T Schroeder; L Shear; S M Sancetta; G J Gabuzda
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

5.  Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease.

Authors:  M H Koppel; J W Coburn; M M Mims; H Goldstein; J D Boyle; M E Rubini
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

6.  Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis.

Authors:  Søren Møller; Lise Hobolth; Christine Winkler; Flemming Bendtsen; Erik Christensen
Journal:  Gut       Date:  2011-04-19       Impact factor: 23.059

Review 7.  Hepatorenal syndrome.

Authors:  Pere Ginès; Mónica Guevara; Vicente Arroyo; Juan Rodés
Journal:  Lancet       Date:  2003-11-29       Impact factor: 79.321

Review 8.  Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.

Authors:  Narci C Teoh; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

9.  Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.

Authors:  A Maroto; A Ginès; J Saló; J Clària; P Ginès; L Anibarro; W Jiménez; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

10.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  6 in total

1.  High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes.

Authors:  Haruka Saito; Hayato Tanabe; Akihiro Kudo; Noritaka Machii; Moritake Higa; Satoshi Yamaguchi; Gulinu Maimaituxun; Kazumichi Abe; Atsushi Takahashi; Kenichi Tanaka; Koichi Asahi; Hiroaki Masuzaki; Hiromasa Ohira; Junichiro J Kazama; Michio Shimabukuro
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 2.  Acute kidney injury in children with chronic liver disease.

Authors:  Akash Deep; Romit Saxena; Bipin Jose
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

Review 3.  Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia.

Authors:  Jianxia Wen; Xing Chen; Shizhang Wei; Xiao Ma; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-24       Impact factor: 2.629

Review 4.  Organ crosstalk: the potent roles of inflammation and fibrotic changes in the course of organ interactions.

Authors:  Ferah Armutcu
Journal:  Inflamm Res       Date:  2019-07-20       Impact factor: 4.575

Review 5.  Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment.

Authors:  Elise J Smolders; Clara T M M de Kanter; Bart van Hoek; Joop E Arends; Joost P H Drenth; David M Burger
Journal:  Drug Saf       Date:  2016-07       Impact factor: 5.606

6.  Liberation From Renal Replacement Therapy After Cadaveric Liver Transplantation.

Authors:  Ibtesam A Hilmi; Ali Al-Khafaji; Daniela Damian; Bedda L Rosario-Rivera; Ali Abdullah; John A Kellum
Journal:  Transplant Direct       Date:  2016-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.